BCL2 and Alzheimer disease: It dose-dependently improved behavioral performance in AD mice, increased BDNF and TrkB expression, and alleviated neuronal apoptosis via the ERK1/2 and PI3K-AKT-GSK-3β pathways, and upregulated the Bcl-2/Bax ratio.